Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

NIH report on marijuana therapy released

Aug. 14, 1997

SIBIA Neurosciences and Lilly near completion of VGCC research collaboration

Aug. 14, 1997

Myotrophin NDA review period extended by FDA

Aug. 14, 1997

Tuberous sclerosis complex gene identified

Aug. 14, 1997

YM-872 shows potential for stroke in animal models

Aug. 13, 1997

Antiischemic activity of calmodulin antagonist reported

Aug. 13, 1997

NR2B-selective NMDA antagonist for occlusive stroke

Aug. 13, 1997

Bradykinin antagonist shows potential in stroke and ischemic disorders

Aug. 13, 1997

YM90K efficacy shown in rat model of cerebral ischemia

Aug. 13, 1997

Endothelin antagonists for cerebral ischemia

Aug. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Will Ovid’s golden age of KCC2 metamorph CNS?
BioWorld
The “deep dive” April 8 by Ovid Therapeutics Inc. into potassium-chloride co-transporter 2 (KCC2) research included company officials and independent experts in...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...